(Q42478441)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Maria Gisella Cavallo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

P Pozzilli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

N Visalli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Signore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R Buzzetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M L Boccuni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Fava

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Gragnoli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Andreani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

848-852

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7556988%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s001250050362

20 October 2019

exact match

0 references

cites work

Nicotinamide--biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992.

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

Intervention therapies for insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050362

21 January 2018

1 reference

12 December 2020

Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group

1 reference

12 December 2020

Double-blind randomized trial of nicotinamide on early-onset diabetes

1 reference

12 December 2020

Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Nicotinamide may extend remission phase in insulin-dependent diabetes

1 reference

12 December 2020

Nicotinamide increases C-peptide secretion in patients with recent onset type 1 diabetes

1 reference

12 December 2020

HLA-DQA1 and DQB1 gene polymorphisms in type I diabetic patients from central Italy and their use for risk prediction

1 reference

12 December 2020

Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide

1 reference

12 December 2020

Nicotinamide and prevention of diabetes

1 reference

12 December 2020